Assessment of possible nephrotoxicity from iohexol in patients with normal and impaired renal function

References

• Almén T. Experimental investigations with iohexol and their clinical relevance. Iohexol — Omnipaque. Clinical experience with a new non-ionic contrast medium, E. Boijsen, T. Aakhus, 1983; 17, Acta Radiol. Suppl. 366
   Google Scholar
• Alving A. S., Miller B. F. A practical method for the measurement of glomerular filtration rate (inulin clearance). Arch. Intern. Med. 1940; 66: 306
   Google Scholar
• Barret B. J., Carlisle E.-J. Meta-analysis of the relative nephrotoxicity of high and low osmolality iodinated contrast media. Radiology 1993; 188: 171
   PubMed Web of Science ®Google Scholar
• Barret B. J., Parfrey P. S., Vavasour H. M., et al. Contrast nephropathy in patients with impaired renal function. High versus low osmolar media. Kidney Int. 1992; 41: 1274
   PubMed Web of Science ®Google Scholar
• Berns J. S., Rudnick M. R. Radiocontrast media associated nephrotoxicity. Kidney 1992; 24: 1
   Google Scholar
• Berg K. J., Jakobsen J. Nephrotoxicity related to contrast media. Patient safety and adverse events in contrast medium examinations, I. Enge, J. Edgren. Congress Series 816, Excerpta Medica, Amsterdam 1989; 112
   Google Scholar
• Billström Å., Hietala S.-O., Lithner F., Merikanto J., Wirell M., Wirell S. Nephrotoxicity of contrast media in patients with diabetes mellitus. A comparative urographic and angiographic study with iohexol and metrizoate. Acta Radiol. 1989; 30: 509
   PubMed Web of Science ®Google Scholar
• Boijsen M., Jacobsson L., Tylén U. Renal function measured with X-ray fluorescence analysis. A comparison between contrast medium clearance and non-simultaneous 51Cr-EDTA clearance. Acta Radiol. Diagn. 1987; 28: 581
   Google Scholar
• Brown S. C. W., O'Reilly P. H. The estimate of glomerular filtration rate during urography. Acceptability of a nonionic contrast medium as a marker of renal function. Invest. Radiol. 1992; 27: 774
   PubMed Web of Science ®Google Scholar
• Dahlström K. Summary of US and European intravascular experience with iohexol. Invest. Radiol. 1985; 20: 117
   Web of Science ®Google Scholar
• Dawson P., Trewhella M. Intravascular contrast agents and renal failure. Clin. Radiol. 1990; 41: 373
   PubMed Web of Science ®Google Scholar
• Dodge W. F., Travis L. D., Daeschner C. W. Comparison of endogenous creatinine clearance with inulin clearance. Am. J. Dis. Child. 1967; 113: 683
   PubMedGoogle Scholar
• Effersøe H., Rosenkilde P., Groth S., Jensen L. I., Golman K. Measurement of renal function with iohexol. A comparison of iohexol 99mTc-DTPA and 51Cr-EDTA clearance. Invest. Radiol. 1990; 25: 778
   PubMed Web of Science ®Google Scholar
• Edelson J., Shaw D., Palace G. Pharmacokinetics of iohexol, a new nonionic radiocontrast agent in humans. J. Pharm. Sci. 1984; 73: 993
   PubMed Web of Science ®Google Scholar
• Edgren J., Laasonen L., Groop P.-H., Groop L. Iohexol and metrizoate in urography of insulin dependent patients. Acta Radiol. Diagn. 1986; 27: 265
   PubMedGoogle Scholar
• Ekelund L. Iohexol in urography. Survey and present state. Acta Radiol. 1983, Suppl. 366: 25
   Google Scholar
• Frennby B., Sterner G., Almén T., Hagstam K.-E., Hultberg B., Jacobsson L. The use of iohexol clearance to determine GFR in patients with severe chronic renal failure — a comparison between different clearance techniques. Clin. Nephrol. 1995; 43: 35
   PubMed Web of Science ®Google Scholar
• Golman K., Almén T. Contrast media induced nephrotoxicity. Survey and present state. Invest. Radiol. 1985; 20: 92
   Web of Science ®Google Scholar
• Harris K. G., Smith T. P., Cragg A. H., Lemke J. H. Nephrotoxicity from contrast material in renal insufficiency. Ionic versus nonionic agents. Radiology 1991; 179: 849
   PubMed Web of Science ®Google Scholar
• Hietala S.-O., Almén T. Patient risk factor of importance in nephrotoxicity of contrast media. Patient safety and adverse events in contrast medium examinations, I. Enge, J. Edgren. Congress Series 816, Excerpta Medica, Amsterdam 1989; 121
   Google Scholar
• Hill J. A., Winniford M., Cohen M. D., et al. Multicenter trial of ionic versus nonionic contrast media for cardiac angiography. Am. J. Cardiol. 1993; 72: 770
   PubMed Web of Science ®Google Scholar
• Hood B., Attman P. O., Ahlmén J., Jagenburg R. Renal haemodynamics and limitations of creatinine clearance in determining glomerular filtration rate in glomerular disease. Scand. J. Urol. Nephrol. 1971; 5: 154
   PubMedGoogle Scholar
• Hunter J. V., Kind P. R. N. Nonionic iodinated contrast media. Potential renal damage assessed with enzymuria. Radiology 1992; 183: 101
   PubMed Web of Science ®Google Scholar
• Jakobsen J., Kolbenstvedt A. N., Levorstad K., Berg K. J., Enge I. Renal effects of nonionic contrast media after intravenous, cardiac and lumbar aortic injections. Invest. Radiol. 1990; 25: 135
   Web of Science ®Google Scholar
• Jeunikar A. M., Finnie K. J. C., Dennis B., Plummer D. F., Avila A., Linton A. L. Nephrotoxicity of high and low osmolality contrast media. Nephron 1988; 48: 300
   PubMed Web of Science ®Google Scholar
• Krutzén E., Bäck S. E., Nilsson-Ehle I., Nilsson-Ehle P. Plasma clearance of a new contrast agent, iohexol. A method for the assessment of glomerular filtration rate. J. Clin. Med. 1984; 104: 955
   PubMed Web of Science ®Google Scholar
• Lautin E. M., Freeman N. J., Schoenfeld A. H., et al. Radiocontrast-associated renal dysfunction. Incidence and risk factors. AJR 1991; 157: 49
   PubMed Web of Science ®Google Scholar
• Lautin E. M., Freeman N. J., Schoenfeld A. H., et al. Radiocontrast-associated renal dysfunction. A comparison of lower osmolality and conventional high osmolality contrast media. AJR 1991; 157: 59
   PubMed Web of Science ®Google Scholar
• Levorstad K., Vatne K., Brodahl U., Laake B., Simonsen S., Aakhus T. Safety of nonionic contrast medium Omnipaque in coronary angiography. Cardiovasc. Intervent. Radiol. 1989; 12: 98
   PubMed Web of Science ®Google Scholar
• Lewis R., Kerr N., van Buren C., et al. Comparative evaluation of urographic contrast media, inulin, and 99mTc-DTPA clearance methods for determination of glomerular filtration rate in clinical transplantation. Transplantation 1989; 48: 790
   PubMed Web of Science ®Google Scholar
• Miller B. F., Winkler A. W. The renal excretion of endogenous creatinine in man. Comparison with endogenous creatinine and inulin. J. Clin. Invest. 1938; 17: 31
   PubMedGoogle Scholar
• Moore R. D., Steinberg E. P., Powe N. R., et al. Nephrotoxicity of high-osmolality versus low-osmolality contrast media randomized clinical trial. Radiology 1992; 182: 649
   PubMed Web of Science ®Google Scholar
• Olsson B., Aulie Å., Sveen K., Andrew E. Human pharmacokinetics of iohexol. A non-ionic contrast medium. Invest. Radiol. 1983; 18: 177
   PubMed Web of Science ®Google Scholar
• Parfrey P. S., Griffiths S. M., Barret B. J., et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. New Engl. J. Med. 1989; 320: 143
   PubMed Web of Science ®Google Scholar
• Schrott K. M., Behrends B., Clauss W., Kaufmann J., Lehnert J. Iohexol in excretory urography. Results of the drug monitoring programme. Fortschr. Med. 1986; 104: 153
   PubMedGoogle Scholar
• Shemesh O., Golbetz H., Kriss J., Myers B. Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int. 1985; 28: 830
   PubMed Web of Science ®Google Scholar
• Stegmayr B., Björck L.-M., Kempi V., Semb H. Renal function not impaired by hip arthroplasty. A prospective study of 30 patients. Acta Orthop. Scand. 1992; 63: 7
   PubMed Web of Science ®Google Scholar
• Thomsen H. S. Contrast nephropathy. Current Opin. Radiol. 1990; 2: 793
   PubMedGoogle Scholar
• Thomsen H. S., Hvid-Jacobsen K. Estimation of glomerular filtration rate from low-dose injection of iohexol and a single blood sample. Invest. Radiol. 1991; 26: 332
   PubMed Web of Science ®Google Scholar
• van Lente F., Suit P. Assessment of renal function by serum creatinine and creatinine clearance. Glomerular filtration rate estimated by four procedures. Clin. Chem. 1989; 35: 2326
   PubMed Web of Science ®Google Scholar